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Abstract
Background: Epithelial cells of the urinary tract recognize pathogenic bacteria through pattern recognition
receptors on their surface, such as toll-like receptors (TLRs), and mount an immune response through the
activation of the NF-kappaB pathway. Some uropathogenic bacteria can subvert these cellular responses, creating
problems with how the host eliminates pathogens. Lactobacillus is a genus of lactic acid bacteria that are part of
the microbiota and consist of many probiotic strains, some specifically for urogenital infections.
Immunomodulation has emerged as an important mode of action of probiotic and commensal lactobacilli and
given the importance of epithelial cells, we evaluated the effect of the urogenital probiotic Lactobacillus rhamnosus
GR-1 on epithelial immune activation.
Results: Immune activation through the NF-kappaB pathway was initiated by stimulation of T24 urothelial cells with
heat-killed Escherichia coli and this was further potentiated when cells were co-cultured with live L. rhamnosus GR-1.
Heat-killed lactobacilli were poor activators of NF-kappaB. Concomitant stimulation of bladder cells with E. coli and L.
rhamnosus GR-1 increased the levels of the pro-inflammatory cytokine TNF, whereas IL-6 and CXCL8 levels were reduced.
Another probiotic, L. rhamnosus GG, was also able to potentiate NF-kappaB in these cells although at a significantly
reduced level compared to the GR-1 strain. The transcript numbers and protein levels of the lipopolysaccharide receptor
TLR4 were significantly increased after co-stimulation with E. coli and lactobacilli compared to controls. Furthermore,
inhibition of TLR4 activation by polymixin B completely blocked the lactobacilli potentiation of NF-kappaB.
Conclusions: The immunological outcome of E. coli challenge of bladder cells was influenced by probiotic L.
rhamnosus GR-1, by enhancing the activation of NF-kappaB and TNF release. Thus the urogenital probiotic L.
rhamnosus GR-1 modulated the activation of the NF-kappaB through increased levels of TLR4 on the bladder cells
and altered subsequent release of cytokines from urothelial cells. By influencing immunological factors such as
TLR4, important in the process of fighting pathogens, lactobacilli could facilitate pathogen recognition and
infection clearance.
Background
Many bacterial diseases, including urinary tract infections
(UTIs) are initiated by microorganisms adhering to and
colonizing the epithelium. Epithelial cells of the urinary
tract (urothelial cells) respond to pathogens by producing
various immune activating substances including com-
pounds that recruit immune cells such as macrophages.
Epithelial cells express a number of different pattern
recognition receptors such as toll-like receptors (TLRs)
t h a ta r ea b l et ot r i g g e rt h ee x p r e s s i o no fi n f l a m m a t o r y
mediators and subsequent inflammation in the presence of
pathogenic microbes. One of the most studied TLRs is
TLR4, which binds lipopolysaccharides (LPS) found on the
cell wall of Gram-negative bacteria [1]. Key proteins
involved in inflammation are the Rel/Nuclear Factor (NF)-
B proteins, which once activated can induce the transcrip-
tion of several immunologically essential molecules, such as
tumor necrosis factor (TNF), interleukin (IL)-6 and CXCL8
[2-4]. These cytokines are very important in the antimicro-
bial and inflammatory process and they effectively recruit
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NF-B transcription factor is located within the cytosol,
where inhibitory proteins masking the nuclear localization
signal impair its nuclear migration. During NF-B activa-
tion, the inhibitory proteins are disassociated from the
transcription factor dimer, which is subsequently trans-
ported into the nucleus [5]. Nuclear translocation of NF-
B during infectious processes is important for the subse-
quent activation of immune responses.
The most prevalent cause of UTI is uropathogenic
Escherichia coli (UPEC), which expresses numerous viru-
lence factors including toxins and fimbriae used for adhe-
sion. Eukaryotic cells can identify pathogens, for example
when type 1 fimbriae, P-pili, or LPS bind to TLR4 and eli-
cit an inflammatory response, albeit via different intracel-
lular pathways [6]. However, some UPEC are equipped
with virulence factors that can block immune responses
allowing the organisms to freely multiply. These UPEC
can act directly on TLR activation, inhibiting NF-Ba ta n
early stage after ligand binding and consequently, there is
no transcription of the integral components needed to
m o u n ta ni m m u n er e s p o n s e[ 7 ] .S i m i l a r l y ,al o wT L R 4
expression or activity is associated with increased UTI sus-
ceptibility. Such strategies would impede pathogen clear-
ance in vivo and cause recurrent UTIs [8,9].
Lactobacillus is a genus of Gram-positive bacteria natu-
rally found in the healthy human vagina [10] and urethra
[11]. Moreover, a low Lactobacillus count is inversely
related to high numbers of E. coli in the vagina and a
history of recurrent UTI [12]. Several lactobacilli strains
are used as probiotics to prevent infections within the
gastrointestinal and urogenital tracts as well as to amelio-
rate allergic and inflammatory conditions [13-15]. The
probiotic mechanisms are believed to include the release
of antibacterial substances, biosurfactant production,
disruption of biofilms and competitive exclusion [16].
Furthermore, the ability of probiotic strains to modulate
immunity through NF-B and mitogen activated protein
(MAP) kinase pathways, both important in the develop-
ment of innate and adaptive immunity, has been reported
[17,18]. Lactobacillus rhamnosus GR-1 is a probiotic iso-
lated from a female urethra [19] used to prevent UTI and
bacterial vaginosis, and it has both immunomodulatory
and antimicrobial activity [20,21]. Currently, the immu-
nological effects of lactobacilli on urothelial cells are in
large part unexplored. The aim of this current study was
to investigate how L. rhamnosus GR-1 can affect urothe-
lial immune responses to E. coli.
Results
Bladder cells responded poorly to lactobacilli compared
to heat-killed E. coli
E. coli are potent activators of epithelial immune
responses and were therefore used to stimulate activation
of NF-B and cytokine release from bladder cells. After
24 h of challenge with heat-killed E. coli, cells responded
with more than 10-fold increase in NF-Ba c t i v a t i o n
compared to resting cells, as measured by the luciferase
reporter assay (Figure 1A). Furthermore, challenge gave a
substantial increase in pro-inflammatory TNF, IL-6, and
CXCL8 levels (Figure 1B, C, and 1D). On the other hand,
L. rhamnosus GR-1 was a poor activator of NF-B. Sti-
mulation with viable lactobacilli led to a minor increase
in the activation of NF-B while heat-killed bacteria had
no significant effect (Figure 2A). Although viable lactoba-
cilli could marginally increase NF-B activation com-
pared to resting cells, stimulation did not promote
release of any of the tested cytokines (TNF, IL-6 and
CXCL8). In contrast, it resulted in a small but significant
reduction of CXCL8, compared to resting cells, while
TNF and IL-6 levels were unaffected (Figure 2B).
Lactobacilli do not normally come into contact with
bladder cells, therefore we determined the cytotoxicity
caused by lactobacilli exposure. However, we did not
observe decreased epithelial cell viability compared to
* *
*
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Figure 1 NF-B activation and expression of cytokines in
bladder cells after E. coli challenge. Bladder cells were stimulated
with heat-killed E. coli for 24 h at a concentration corresponding to
10
8 cfu/ml. (A) Relative NF-B activation was measured by luciferase
activity (n = 4) and the protein levels of (B) TNF, (C) IL-6, and (D)
CXCL8 were measured by ELISA (n = 3). Error bars represent the
standard errors of the means. Bars labeled with an asterisk
significantly differ from the control (p-values < 0.05).
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stained cells and flow cytometry (data not shown).
Viable lactobacilli potentiated NF-B activation and
cytokine response in E. coli-stimulated cells
Bladder cells were relatively indifferent towards stimula-
tion with both viable and heat-killed lactobacilli,
whereas the cells responded appropriately towards sti-
mulation with E. coli, leading to increased NF-B activa-
tion and release of inflammatory mediators. Co-
stimulation with viable lactobacilli and heat-killed E. coli
did however result in increased NF-B activation com-
pared to cells challenged with E. coli alone (Figure 3A).
This NF-B induction was beyond an eventual additive
effect, representing a synergistic action on NF-B activa-
tion. On the protein level, co-stimulation influenced the
release of all studied inflammatory mediators. The TNF
release was increased by a factor of two to three, while
IL-6 and CXCL8 levels were reduced compared to those
found during E. coli challenge alone (Figure 3B).
NF-B activation was significantly reduced when blad-
der cells were exposed to heat-stable cell wall compo-
nents of lactobacilli (Figure 3A), indicating that
potentiation was mediated by compound(s) released
during the growth of L. rhamnosus GR-1.
L. rhamnosus GR-1 and GG augmented NF-B to different
levels
Lactobacillus rhamnosus GG, a well-studied immunomo-
dulatory strain used for gastrointestinal disorders, was
chosen to compare NF-B augmenting abilities. Both L.
rhamnosus GR-1 and GG had the ability to potentiate E.
coli induced NF-B activation (Figure 4). While L. rham-
nosus GG induced NF-Bt w o f o l d ,L. rhamnosus GR-1
showed a three- to fourfold induction of NF-Bc o m -
pared to cells that had no lactobacilli added.
*
*
*
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Figure 2 NF-B activation and expression of cytokines in bladder cells after stimulation with L. rhamnosus GR-1. Viable (V) or heat-killed
(HK) L. rhamnosus GR-1 at a concentration of 2 × 10
7 cfu/ml were used to challenge bladder cells for 24 h. (A) Relative NF-B activation (n =4 )
and (B) TNF, IL-6, and CXCL8 levels (n = 3) were measured using luciferase assay and ELISA, respectively. Error bars represent the standard errors
of the means. Bars labeled with an asterisk significantly differ from the control (p-values < 0.05).
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T L R 4i sac r u c i a lp r o t e i ni nt h ed e t e c t i o no fE. coli by
epithelial cells, therefore we proceeded by analyzing the
levels of TLR4 in bladder cells treated with heat-killed
E. coli and L. rhamnosus GR-1. Co-stimulated bladder
cells showed increased expression of TLR4 mRNA com-
pared to cells stimulated with E. coli or lactobacilli
alone (Figure 5A). Furthermore, immunoblotting using
native proteins showed high band intensity in co-stimu-
lated cells suggesting higher TLR4 protein content com-
pared to all other groups (Figure 5B). The effect on
TLR4 protein levels was further characterized using con-
focal laser microscopy. Control cells and cells stimulated
with only E. coli or lactobacilli showed no or low TLR
expression, whereas cells co-stimulated with both E. coli
and L. rhamnosus GR-1 demonstrated a substantial
increase in the amount of TLR4 protein (Figure 5C).
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Figure 3 NF-B activation and cytokine secretion after concomitant stimulation with E. coli and L. rhamnosus GR-1. Bladder cells were
challenged for 24 h with heat-killed E. coli alone or together with viable (V) or heat-killed (HK) L. rhamnosus GR-1. (A) Relative NF-B activation
(n = 4). (B) TNF, IL-6 and CXCL8 levels (n = 3) were measured. Bars labeled “a” are significantly different from control and “b” significantly
different from cells stimulated with E. coli (p-values < 0.05).
*
E. coli - +++
L. rhamnosus -- GR-1 GG
Figure 4 NF-B augmentation by two different L. rhamnosus
strains. Bladder cells were co-stimulated with heat-killed E. coli and
viable L. rhamnosus GR-1 or L. rhamnosus GG for 24 h (n = 4). An
asterisk denotes significant difference between the two groups (p-
values < 0.05).
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Figure 5 TLR4 expression in bladder cells after Lactobacillus stimulation.( A) TLR4 qPCR from cells co-stimulated for 3 h with E. coli and L.
rhamnosus GR-1 (n = 3). (B) A native immunoblot of TLR4 protein after 24 h stimulation. (C) Confocal microscopy of TLR4 protein (green pixels)
after stimulation of T24 cells. The cells were also stained with DAPI (DNA stain) and Alexa555 phalloidin (actin stain) and pseudo-colored blue
and red, respectively. Immunoblot and confocal images are representative data from two or more separate experiments. Bars labeled with an
asterisk are significantly different from control cells (p-values < 0.05).
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We continued to characterize the role of TLR4 in NF-B
activation by co-stimulation with heat-killed E. coli and
lactobacilli. The TLR4 activation in bladder cells was
inhibited by pretreatment with polymyxin B, a known
inhibitor of LPS-induced TLR4 activation, and thereafter
stimulated by E. coli and L. rhamnosus GR-1 (Figure 6).
Polymyxin B significantly inhibited NF-B activation in
cells challenged with both E. coli and lactobacilli
although it had no significant effect on NF-B activation
in resting cells and on lactobacilli treated cells. The
increased NF-B activation observed during co-stimula-
tion was completely lost after polymyxin B treatment,
demonstrating the involvement of LPS and TLR4.
Discussion
Activation of NF-B during infection has a profound
effect on the expression of multiple targets which guide
the maturation of immune responses against invading
pathogens [22]. Recently, much attention has been given
to the immunomodulatory activities of the microbiota
and various probiotic organisms. Studies have shown a
L. plantarum probiotic to be effective at modulating
immunity through NF-B and MAP kinase signaling in
a number of cell types including mucosal epithelial cells
[23]. In this study we showed the immunomodulatory
effects of a urogenital probiotic, L. rhamnosus GR-1 on
human bladder cells. In order to activate the urothelial
cell defense mechanisms in a way that resembles the
response during a UTI, including NF-B and cytokine
release, we challenged the cells with heat-killed E. coli.
Although only live bacteria are active in the infection
process, we wanted to reduce the microbe-to-microbe
signaling present between vi a b l eb a c t e r i aa sw e l la st h e
effects of E. coli metabolites on cell cultures [24]. Our
results showed that bladder cells challenged with heat-
killed E. coli and subjected to stimulation with L. rham-
nosus GR-1 exhibited increased NF-Ba c t i v a t i o na n d
TNF release.
The finding that L. rhamnosus does indeed have immu-
nomodulatory properties is not new per se, but most pre-
vious experiments have been done using immune cells
[20,25]. Adjuvant properties of Lactobacillus species have
been demonstrated in several in vivo models. An L. casei
strain boosted immunoglobulin (Ig)A secretion in a
mouse model of Salmonella typhimurium infection [26].
Another effectively potentiated IgG responses after sub-
cutaneous vaccination of chickens towards Newcastle
disease virus and infectious bronchitis virus [27]. Collec-
tively, these studies provide evidence that lactobacilli can
be used for potentiating immune responses in vivo.
Nevertheless, although TNF was upregulated by L. rham-
nosus GR-1 treatment, anti-inflammatory properties of
lactobacilli are well established [25]. In our study, both
IL-6 and CXCL8 were modulated differently from TNF,
where both were down-regulated after lactobacilli treat-
ment of E. coli-challenged cells. These effects might
represent an alternative influence of L. rhamnosus GR-1
on epithelial immune function, guided by transcription
factors other than NF-B, such as MAP kinase/AP-1
pathways or post-transcriptional regulation of NF-B-
regulated genes. Another possibility is that L. rhamnosus
GR-1 produces substances that can interfere with cyto-
kine release from the cell or cytokine stability in the
extracellular space.
Probiotic health benefits have been shown to be some-
what strain specific. In this study, we showed that two
strains exhibit different abilities to increase activation of
NF-B. L. rhamnosus GG elicited a weaker potentiation of
E. coli-induced NF-B activation than L. rhamnosus GR-1.
Heat-killed preparations of L. rhamnosus GR-1 marginally
augmented NF-B, in a manner similar to using viable
L. rhamnosus GG (below twofold). It is possible this aug-
mentation is due to surface-associated structures shared
by both strains. Lactobacilli surface components have pre-
viously been shown to modulate NF-Bi nac o n t a c t -
dependent manner [17]. T24 cells express TLR2, and can
recognize lipoteichoic acid (LTA) found on the surface of
lactobacilli with increased NF-B activation as a conse-
quence [28]. However, since heat-killed lactobacilli only
slightly induced NF-B activation that is not a likely
mechanism given that LTA is anchored to the Gram-posi-
tive cell wall. A more probable mechanism is that products
released during bacterial growth are responsible for the
NF-Ba u g m e n t a t i o nb yL. rhamnosus GR-1. We have
previously shown that spent culture supernatant from
L. rhamnosus GR-1 can augment NF-B activation in
a
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L. rhamnosus - - ++
Figure 6 NF-B potentiation is TLR4 dependant. Polymyxin B
(PMB) was added to cell culture before stimulation to inhibit TLR4
activation. Cells were stimulated with heat-killed E. coli and viable L.
rhamnosus GR-1 for 24 h (n = 3). Bars labeled “a” are significantly
different from control and “b” significantly different from E. coli
stimulated cells (p-values < 0.05).
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Page 6 of 10E. coli-challenged T24 cells [29]. There are no published
studies on the identity of the secreted proteins from
L. rhamnosus GR-1. However L. rhamnosus GG is known
to release a small number of proteins during growth, none
of which have an established immunomodulatory effect
[30]. A comparison of secretory proteins from the two
strains might help explain the differences in terms of
immune potentiation.
The role of TLR4 was evaluated by blocking LPS bind-
ing to the receptor using polymyxin B, which eliminated
the observed NF-kB potentiation. We initially saw that
expression of TLR4 at genetic and protein levels was
increased during co-stimulation compared to controls, or
during individual stimulation with E. coli or lactobacilli.
Although TLR4 has LPS as a natural ligand, other E. coli
c o m p o n e n t ss u c ha sp i l ih a v eb e e ns h o w nt ob ea b l et o
activate TLR4. However, in this study, polymyxin B com-
pletely inhibited NF-B activation in E. coli stimulated
cells, therefore pili or other surface structures could not
have contributed to this effect [31]. We consider that an
increased number of TLR4 present on the cell facilitated
activation by ligands on E. coli and lactobacilli alike.
TLRs are important in UTI disease progression, as
s h o w ni nC 3 H / H e Jm i c ew i t ham u t a t i o ni nt h eTlr4
gene. After an E. coli infection, these mutant mice have
problems removing the pathogens from their urinary
tract [32]. A recent study scoring TLR4 expression levels
in healthy control subjects and UTI patients showed that
the latter have a lower TLR4 expression than healthy
controls [9]. This important feature of TLR4 is consistent
with the effect that certain E. coli strains expressing
immunomodulatory compounds have on TLR signaling
and NF-B activation. The effect of lactobacilli on NF-
B, TNF and TLR4 represents one possibility that
increases the urothelial immune cell responses. This aug-
mentation might facilitate early detection and clearance
of pathogens.
As defined by FAO/WHO, probiotic microbes must be
alive when administered in order to confer health bene-
fits [33]. The in vitro effects on NF-B augmentation has
been reported to be dependent on lactobacilli viability,
since after heat-killing they only had a marginal effect on
NF-B activation in co-stimulation experiments with
E. coli. This supports modulation of NF-B as a potential
probiotic mechanism. The ability of probiotic lactobacilli
to interfere with UPEC colonization in the vagina, and
thereby the pathogens’ ascension into the bladder, could
therefore involve immunomodulatory activity, specifically
via NF-B activation.
Conclusions
The main cause of UTI is ascending E. coli that colo-
nizes the vagina, urethra then bladder. To remove
unwanted pathogens, the urothelial cells of the mucosa
carry specific receptors, such as TLR4 that can recog-
nize the most common Gram-negative species. Once
these receptors bind the cognate bacterial ligand, the
epithelial cells respond by producing a range of com-
pounds including cytokines that are strongly regulated
by the NF-B transcription factor. The present in vitro
study showed that this immune activation could be
amplified by probiotic L. rhamnosus GR-1. Moreover,
augmentation of NF-B was accompanied by an increase
in inflammatory TNF expression. The important recog-
nition molecule TLR4 was found to be up-regulated by
L. rhamnosus GR-1 on both mRNA and protein level in
cells concomitantly challenged with E. coli.M o r e o v e r ,
the blocking agonist binding to TLR4 completely inhib-
ited the augmentation of NF-Bb yL. rhamnosus GR-1.
Due to the importance of TLR4 in the process of patho-
gen clearance we suggest that this represents a pathway
in which probiotic immunomodulatory lactobacilli work
to increase immunity and prevent infections.
Methods
Cell culture
The T24 human bladder carcinoma cell line (ATCC
HTB-4) was cultured in RPMI 1640 (Hyclone) supple-
mented with 2.05 mM of L-glutamine and 10% fetal
bovine serum (FBS; Hyclone) at 37°C with 5% CO2 in a
humidified environment.
Bacterial strains and growth conditions
L. rhamnosus GR-1 (urethral isolate) and GG (intestinal
isolate) were cultured on de Man Rogosa Sharp (MRS)
agar (Difco) anaerobically using anaerobic packs (BD) at
37°C for 24 h under static condition. For cell culture
challenge, lactobacilli were grown from a 1% inoculum in
MRS broth for 24 h followed by washing and resuspend-
ing in the original volume with phosphate buffered saline
(PBS; pH 7.4). Uropathogenic E. coli GR12 was grown in
Luria-Bertani (LB) medium (Difco) at 37°C and constant
shaking. Heat-killed bacteria were prepared by washing
cultures in PBS and heating at 70°C for 1 h followed by
plating 100 μl on the respective growth medium (MRS or
LB) to confirm loss of viability. Heat-killed L. rhamnosus
GR-1 and E. coli were stored at -20°C until used for cell
challenge.
Transfection and luciferase reporter assay
To detect activation of NF-B, a luciferase vector com-
posed of multiple B enhancer regions followed by the
firefly luciferase gene was used (pNFB-Luc, Clontech). A
vector with constitutively active Renilla luciferase (pRL-
CMV, Promega) was chosen as internal control. One day
prior to transfection, approximately 0.5 × 10
5 cells per
well were seeded in a 24-well format. Transfection was
performed for 6 h using 1.5 μl/well of Lipofectamine
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μg/well of pRL-CMV. Lipofectamine 2000 and plasmids
were diluted in serum-free Opti-MEM (Invitrogen) during
preparation of DNA-liposome complexes. All plasmids
were isolated by an endofree plasmid isolation kit
(Macherey-Nagel) according to the manufacturer’s
instructions. Luciferase was detected using the dual-luci-
ferase reporter assay system (Promega) and a Turner
TD20/20 luminometer (Turner biosystems) set to 10s
measurement with an initial 2s delay. Transcription factor
activation was expressed as relative NF-Ba c t i v a t i o n ,
defined as the ratio between firefly luciferase and Renilla
luciferase activity. Ratios were normalized against either
non-stimulated control cells or cells stimulated with
E. coli. The difference between means was tested statisti-
cally by using Student’s t-test, with the limit for statistical
significance set to p-values < 0.05.
Epithelial cell line challenge
T24 bladder cells transfected with luciferase vectors
(pNFB-Luc and pRL-CMV) were challenged for 24 h
in a 24-well plate format with 2 × 10
7 cfu/ml of viable
or the equivalent number of heat-killed lactobacilli
(L. rhamnosus GR-1 or GG). For activation of NF-B, as
well as cytokine and chemokine release, epithelial cells
were stimulated with heat-killed E. coli (10
8 cfu/ml).
Cell culture supernatants for ELISA were collected from
challenge experiments using non-transfected cells and
stored at -20°C until use. For qPCR, cells were stimu-
lated in the same way although all experiments were
done in 6-well plates (with proportional increase in
number of cells and bacteria) for increased amounts of
RNA. Cell viability was determined by staining dead
cells using propidium iodide followed by flow cytometry
(Cytomics FC500, Beckman Coulter). To inhibit agonist
activation of TLR4 in T24 cells, transfected cells were
exposed to Polymyxin B (Invivogen), which effectively
binds to LPS and thereby inhibits TLR4 activation, at a
concentration of 50 μg/ml for 1 h prior to the experi-
ment and subsequently challenged with bacteria, as pre-
viously described.
Enzyme-linked immunosorbent assays
TNF, IL-6 and CXCL8 levels were determined by BD
ELISA sets (BD Biosciences) according to the manufac-
turer’s instructions. A volume of 100 μl of capture anti-
body (diluted 1:250 coating buffer) was added to each
well of a 96-well ELISA microplate (Nunc) and allowed
to bind overnight at 4°C. Wells were washed three times
with PBST (PBS pH 7.0 with 0.05% Tween-20) and
blocked with PBS supplemented with 10% heat-inacti-
vated FBS (HyClone) for 1 h in room temperature after
which the wells were washed three times with PBST. Tis-
sue culture medium from challenged cells was briefly
centrifuged to remove cell debris and 100 μl of the super-
natant or standard was added to the wells and incubated
at room temperature for 2 h. After washing five times
with PBST, 100 μl detection antibody:HRP conjugate
(diluted 1:250 in PBS with 10% heat-inactivated FBS) was
added to the wells and incubated for 1 h at room tem-
perature. After extensive washing (seven times using
PBST), 100 μlo fH 2O2/3,3’,5,5’-tetramethylbenzidine pre-
pared according to the manufacturer’s instructions (TMB
substrate reagent set, BD Biosciences) was added to each
well and incubated at room temperature for 30 min in
the dark. The reaction was stopped with 2 N H2SO4 and
absorbance read at 450 nm using a Multiskan MS plate
reader (Labsystems). Difference between means was
tested statistically by using the Student’s t-test, with the
limit for statistical significance set to p-values < 0.05.
Quantitative polymerase chain reaction
Total RNA was extracted using the Nucleospin RNA II Kit
(Macherey-Nagel) with a DNase treatment step. cDNA
was synthesized from 1 μg of extracted total RNA using
qScript cDNA Synthesis Kit (Quanta Biosciences). Quanti-
tative real time PCR was performed using Perfecta SYBR
Green Fastmix on a Stratagene MX3000 QPCR system
(Agilent Technologies) according to the manufacturer’s
instructions. Primers were designed to bind to different
exons within the genes thereby avoiding risk of genomic
DNA amplification. The primers had a Tm = 60°C with
the following sequences: GAPDH: 5’ CCGTCTA-
GAAAAACCTGCCA 3’ and 5’ TGTGAGGAGGGGA-
GATTCAG 3’;T L R 4 :5 ’ CTGAGCTTTAATCCCCTG
AGGC 3’ and 5’ AGGTGGCTTAGGCTCTGATATGC 3’.
All reactions were run in triplicate. Results were analyzed
using MxPro QPCR software (Agilent Technologies) and
statistics were performed on adjusted ratios using a non-
parametric Mann-Whitney U test. The limit for statistical
significance was set to p-values < 0.05.
Immunoblot
Cells were grown and challenged as previously described
in a six-well format, and thereafter lysed using RIPA buf-
fer. Immunoblotting of cell lysate onto a PVDF membrane
(Amersham Biosciences) was performed using vacuum.
Unbound PVDF sites were blocked with blocking buffer
(Tris-buffered saline, TBS, containing 0.05% Tween-20
and 1% BSA) for 1 h. Blotted membrane was incubated in
primary antibody solution (anti-TLR4, clone HTA125; BD
Biosciences or anti-b-actin, clone AC-15; Sigma-Aldrich)
resuspended in blocking buffer at a concentration of 1 μg/
ml (anti-TLR4) or 10,000 times dilution (anti-b-actin) for
1 h at room temperature and thereafter washed 3 times
for 5 min in wash buffer (TBS and 0.05% Tween-20). For
visualization, the membrane was incubated with the sec-
ondary antibody (anti-mouse IgG HRP-conjugated, GE
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temperature. The membrane was washed 4 times for 5
min using wash buffer before the addition of chemilumi-
nescent substrate (Supersignal west pico, Pierce). Lumi-
nescence was detected using a photographic film (GE
Healthcare). In order to use the loading control antibody
(anti-b-actin), the membrane was stripped using a mild
stripping agent (200 mM glycine, 0.01% (v/v) Tween-20,
3.5 mM SDS, pH 2.2).
Confocal microscopy
Cells were grown in a 6-well format on cover slips over-
night and challenged as described above. The cells were
washed twice in PBS and fixed in 4% paraformaldehyde
for 10 min followed by washing twice for 5 min in PBS.
Cells were permeabilized with PBS containing 0.25%
Triton X-100 (PBST) for 10 min and washed 3 times
with PBS prior to blocking with 1% bovine serum albu-
min in PBST (PBST-BSA) for 30 min. Primary antibody
(anti-TLR4, clone HTA125, BD Biosciences) was added
to cells at a concentration of 0.5 μg/ml in PBST-BSA
and incubated overnight at 4°C. Cells were washed 3
times in PBS and thereafter incubated for 1 h at room
temperature with anti-mouse FITC antibody (BD Bios-
ciences) diluted in PBST-BSA at a concentration of 0.5
μg/ml. FITC-staining was followed by washing with PBS
and subsequent staining of actin using Alexa555 phalloi-
din (Molecular probes) for 30 min at room temperature.
The cells were rinsed with PBS twice and incubated
with a 30 nM DAPI solution for 1 min before mounting
onto glass slides. Fluorescence was observed through a
Fluoview 1000 scanning confocal laser microscope with
the FV10-ASW software (Olympus).
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